Basic Information
Organon & Co. was officially spun off from Merck on March 11, 2020. Organon & Co.'s main products focus on three areas: contraceptives, fertility drugs, and menopause-related treatments. In addition, Organon & Co. also produces medications for mental health, anesthesia, and cardiovascular diseases.
Organon & Co.
NewJersey,United States of America
more than 500 people
March 11, 2020
--